Use of Alternative and Complementary Medications for Menopausal Symptoms - PowerPoint PPT Presentation

1 / 38
About This Presentation
Title:

Use of Alternative and Complementary Medications for Menopausal Symptoms

Description:

75% Caucasian women experience hot flashes, beginning 2 years prior to cessation ... hot flashes in hypogondal men with prostate cancer and in women with ... – PowerPoint PPT presentation

Number of Views:308
Avg rating:3.0/5.0
Slides: 39
Provided by: Roche2
Category:

less

Transcript and Presenter's Notes

Title: Use of Alternative and Complementary Medications for Menopausal Symptoms


1
Use of Alternative and Complementary Medications
for Menopausal Symptoms
  • Lorraine A. Fitzpatrick, M.D.
  • Professor of Medicine
  • Director, Womens Health Fellowship
  • Mayo Clinic and Mayo Foundation

2
  • Im uncertain about
  • taking estrogen. Are there alternative
    medications
  • for hot flashes?

3
Epidemiology of Hot Flashes
  • 75 Caucasian women experience hot flashes,
    beginning 2 years prior to cessation of menses
  • 85 have flashes for more than 1 year
  • 25-50 for 5 years
  • May continue indefinitely
  • More common in Afro-Americans
  • Some cultures have no symptoms

4
Therapies for Hot Flashes
  • Things that do not work very well, if at all
  • Vitamin E
  • Evening primrose oil
  • Soy isoflavones
  • Dong quai
  • Red clover

Naloxone Propranolol Ginseng Yam cream Chinese
Medicinal Herbs
5
Vitamin E and Vitamin C
  • Vitamin E
  • Used since the 1940s
  • Reduced hot flashes only 10 above placebo
  • Flavinoids combined with vitamin C
  • Offensive body odor, stains clothing

6
Soybeans
7
Soy Protein/Isoflavones
  • Genistein and daidzein have estrogen-like effects
    on select target tissues
  • Estrogenic activity, ERbERa
  • Not noted dramatic effects compared to placebo
    (15 over placebo in only one study)
  • Unknown long-term effects on estrogen-sensitive
    tissues soy components stimulate breast tumors
    in nude mice

Albertazzi P et al. Obstet Gynecol 1998916
8
Therapies for Hot Flashes
  • Things that work, but not as good as estrogen
  • Progestins
  • Androgens
  • Tibolone (estrogenic, androgenic and
    progestogenic properties)
  • Alpha-adrenergic agonists
  • Anti-dopaminergic agents
  • Bellergal
  • Selective Serotonin Reuptake Inhibitors

9
Antihypertensives and Hot Flashes
  • Alpha-adrengergic agonists (clonidine,
    lofexidine, methyldopa) reduce hot flashes 20-65
  • Alter neurotransmitters in the hypothalmus to
    regulate thermoregulatory center
  • High dropout rates in clinical trials
  • Dizziness, dry mouth

Clayden JR et al. Br Med J 1974 1409 Hammond MG
et al. J Clin Endocrin Metab 1984 581158 Jones
KP et al. Maturitas 19857135-9.  
10
Antidopaminergic Agents
  • Veralipride is a substituted benzamide derivative
    with anti-dopaminergic (D2) and anti-gonadotropic
    activity
  • Attenuated hot flashes in double-blind study as
    effective as 1.25 mg CEE
  • Not approved for use by FDA in US
  • Associated with mammary gland discharge,
    somnolence, median weight increase of 5
    kilograms, chronic hyperprolactinemia

Source Drugdex Drug Evaluations
11
Bellergal-S
  • Spacetabs
  • Ergotamine tartrate, belladonna alkaloids and
    phenobarbital
  • Reduces hot flashes by 42 over placebo
  • Autonomic system stabilizer that inhibits
    sympathetic-parasympathetic pathway
  • Potential for addiction

Lebherz TB, French LT. Obstet Gynecol.
196933795.
12
SSRIs and Hot Flashes
  • Selective serotonin reuptake inhibitors
  • Efficacy with venlafaxine, paroxetine,
    fluoxetine, sertraline ( 75 compared to 30
    placebo response)
  • Trials in breast cancer patients on SERMs
    suggests effects may be under rated
  • 2-23 experience sexual dysfunction

Stearns V et al. Ann Oncol 20001117-22.
Loprinzi CL et al. J Clin Oncol 1998162377-81.
13
Median Hot Flash Score Reduction in Breast Cancer
Patients
NOT head-to-head trials
Loprinzi C et al
14
Therapies for Hot Flashes
  • Things that might work appropriate trials not
    available
  • SSRIs
  • SERMs
  • Mirtazapine
  • Gabapentin
  • Black cohosh Vitex

15
Gabapentin
  • Related to GABA neurotrainsmittor action not
    established
  • Only preliminary trials, not placebo-controlled
  • Attenuated hot flashes in hypogondal men with
    prostate cancer and in women with breast cancer
  • Associated with anorgasmia in men and women

Guttoso TJ. Neurology 542161, 2000 Loprinizi CL
et al. Mayo Clin Proceedings, in press, Nov 2002 
16
Botanical Medicine
  • Mislabeling and under-labeling
  • Substitution of herbs
  • Presence of toxic metals in a number of
    traditional Chinese medicines
  • Presence of conventional Western pharmaceuticals
    in traditional Chinese medicines
    corticosteroids, NSAIDS, estrogens, progesterone,
    diazepam
  • Inconsistent preparations

Schaumburg HH, Berger A. JAMA 1992
2683430-31. DeSmet PAGM. Drug Safety 1995
1381-93.
17
Black Cohosh
Cimifuga racemosa Black cohosh
18
Cimicifuga Racemosa (Black Cohosh)
  • Inconsistent results from less than rigorous
    trials (7/8 without placebo)
  • Approved and reimbursable in Germany
  • Daily dose of 20 to 40 mg for 6 months
  • 25-30 improvement in attenuation of hot flashes
    over placebo
  • Properties probably not due to estrogen-like
    effects
  • Preparations vary widely!

Liske E. Adv Ther 19981545-53
19
Vitex(Chasteberry)
20
Vitex (Chasteberry)
  • German E commission approves for menstrual
    irregularities and mastodynia
  • Anti-androgenic effects?
  • May raise progesterone levels
  • Proposed mechanisms of action
  • Increases secretion of luteinizing hormone
  • Improves progesterone deficiency
  • Inhibits prolactin

Loch E. Di TW Gynakol 1989 2379. Wuttke W. HN
246, NH 247 Report 1992 87.
21
Other Modalities
  • Meditation, applied relaxation
  • Acupuncture
  • Magnetic therapy (placebo was better)
  • Hypnosis
  • Biofeedback
  • Deep breathing exercises, training paced
    respiration

Towlerton G et al. Palliative Medicine.
13(5)445, 1999 Carpenter JS et al. Cancer
Nursing. 25(2)104-9, 2002 Wijma K. Journal of
Behavior Therapy Experimental Psychiatry.
28(4)251-61, 1997 Freedman RR, Woodward S. Am
J Obstet Gynecol 1992167436-439 Cleary C, Fox
JP. Complement Ther Med 19942181-186
22
Approach to the Patient Who Refuses (or Cant
Take Estrogen)
  • Diary to assess triggers
  • Exercise
  • Smoking cessation
  • Avoid spicy food, caffeine and alcohol
  • Layered clothing
  • Low ambient temperature
  • First line SSRIs
  • Second line Clonidine
  • For the patient who wants to do it naturally
    black cohosh

23
Truth is rarely pure,and never simple.
  • Oscar Wilde

24
Clinical Trials for Hot Flashes
  • Careful patient selection (most trials to date in
    breast cancer patients on SERMs)
  • Placebo controls
  • Double-blind, double-dummy
  • Lead-in period
  • Cross-over trial designs
  • Validated measures and outcomes
  • No confounding medications

25
  • Back up slides

26
Herbal Myths
  • Natural Safe
  • Used for thousands of years Safe
  • Herb as a plant Capsule or Tablet
  • All brands of herbs are the same

27
How Many People Use Dietary Supplements?
  • Estimated 40-55 of Americans use supplements- on
    a regular basis 100 million people
  • Estimated 69 use vitamin mineral supplements
    24 use herbal supplements1
  • Users predominantly adult women 41.8-55 adult
    men 29.7-42.32

1. The Hartman Group, 1998 2. NHANES III,
1988-1994
28
Why Do People Take Dietary Supplements?
  • Feel better
  • Prevent illness
  • Improve recovery when sick
  • Build strength and muscle
  • Doctor suggested taking supplements
  • Live longer
  • Lose weight

Source Yankelovich Partners Inc. for NNFA, 2000
29
How are Consumers Using Herbal Products?
  • 36 are using instead of prescription medication
  • 31 are using with prescription medication
  • 48 are using instead of an non-prescription
  • 30 are using with an non-prescription

Prevention Magazine Survey, May 1999
30
Dietary Supplements in 1999 14.9 Billion
Source Nutrition Business Journal, derived form
a variety of sources
31
Ideal Treatment for Postmenopausal Women
  • Decrease or prevent vasomotor symptoms
  • Increase BMD and decrease fracture risk
  • Neutral or positive effects on cardiovascular
    system
  • Decrease risk for breast cancer
  • Positive cognition and/or libido effects
  • Ease of administration

32
Definition
  • Phytoestrogen is any plant compound structurally
    and/or functionally similar to ovarian and
    placental estrogens and their active metabolites
  • Compounds may have agonistic, partial agonistic,
    and antagonistic interactions with estrogen
    receptors and other targets of estrogenic
    steriods involved in estrogen transport,
    synthesis and metabolism

33
History of Phytoestrogens
  • Queen Annes lace (wild carrot) Contraception
  • Pomegranate Love, fertility
  • Pollens of date palm Fertility induction
  • Moghat root Postpartum beverage
  • Over 300 plants
  • Associated with reduction in chronic diseases
  • Effects vary with concentration, concentration of
    endogenous estrogen, gender and menopausal
    status, variability in colonic microflora

34
Phytoestrogens
  • At least 20 compounds from over 300 plants
  • Herbs (parsley, garlic)
  • Grains (soy beans, wheat, rice)
  • Fruits (dates, cherries, apples)
  • Drinks (coffee and wine)
  • Weaker than natural estrogens
  • Easily broken down, not stored in tissue

35
Clinical Recommendations
  • Postmenopausal women perceive prescription
    estrogens as unnatural
  • Many prescription estrogens are derived from
    plant or other natural sources
  • Potential for problems in premenopausal women,
    but no evidence
  • Reported cases of vaginal bleeding in
    postmenopausal women avoid overuse
  • Recommend moderation in postmenopausal women

36
Womens Health
  • Most American women will spend the last 1/3 of
    their lives post-menopause.
  • While the medical community advocates the use of
    hormone therapy, many women are seeking
    alternative approaches to their menopausal
    symptoms.

37
Soy and Hot Flashes
  • Double-blind 6 month study on menopausal symptoms
  • 69 peri-menopausal women
  • Treatments
  • Isoflavone rich soy protein
  • Isoflavone poor soy protein
  • No effect on vasomotor or menopausal symptoms

A S Germain et al Menopause 8, 17 (2001)
38
Botanical Medicine
  • The sale of dietary supplements and extracted
    herbs is a multi-billion dollar business.
  • Consumers are confused about what supplements to
    use and do not know what to ask.
  • Health care providers are inadequately prepared
    to answer questions.

39
Botanical Medicine
  • Lack of consensus among experts regarding dosage,
    safety, herb-drug interactions, and length of
    treatment.
  • Scientific studies vary in quality, lack of
    objective outcome and measurements, short
    duration and incomplete descriptions.

40
Botanical Medicine
  • What about herb-drug interactions and side
    effects?
  • Opposing mechanisms of actions
  • Anti-coagulants
  • Drugs with a narrow therapeutic window
  • There is absolutely no way of knowing with 100
    certainty which herbs will react with specific
    drugs
  • First trimester of pregnancy

41
Womens Health
  • Menopausal symptoms are usually divided into
    three categories (Greene JG Maturitas 1998
    2925-31)
  • Vasomotor symptoms hot flashes, night sweats
  • Somatic symptoms headaches, joint pain
  • Psychological symptoms depression, irritability

42
Potential Problems?
  • Can isoflavones induce goiter by inhibition of
    thyroid peroxidase?
  • Do isoflavones promote or inhibit breast cancer?
    Other cancer types?
  • Inverse relationship between soy intake and
    testosterone concentrations? Inhibition of 17B
    hydroxyreductase? Male infertility?
  • Decrease follicular cell atresia resulting in
    multiple gestations? Lengthened luteal phase?
  • In men, high levels of tofu associated with low
    cognition scores?
  • Soy for infants causing long-term developmental
    problems?

43
Pathophysiology of Hot Flashes
  • Result from estrogen withdrawal
  • Natural menopause
  • Surgical menopause
  • GnRH agonists or antagonists
  • 75 Caucasian women experience hot flashes,
    beginning 2 years prior to cessation of menses
  • 85 have flashes for more than 1 year
  • 25-50 for 5 years
  • May continue indefinately
  • More common in Afro-Americans
  • Some cultures have no symptoms

44
Pathophysiology of Hot Flashes
  • Vasomotor instability with individual differences
    in frequency, duration and intensity (ave time 4
    minutes)
  • Influenced by environmental and physiologic
    influences
  • Prodrome
  • ?Paroxysmal firing of neurons in temperature
    regulatory center
  • Neuronal firing in reticular activing center
    causes awakening
  • Interactions among catecholamines, prostagladins,
    endorphins, neuropeptides

45
Progestins and Hot Flashes
  • Depo-medroxyprogesterone acetate attenuates hot
    flashes
  • Up to 85 reduction at 150 mg
  • Oral MPA (10 mg qd) reduces by 87
  • Mastalgia, mood changes, bloating, weight gain,
    irregular vaginal bleeding
  • Concerns raised over the WHI results
Write a Comment
User Comments (0)
About PowerShow.com